Market News
Stay updated with the latest market trends, earnings, and economic indicators.

Markets may have bottomed; commodities in focus, IT underweight: Bajaj Finserv AMC
Bajaj Finserv AMC CIO Nimesh Chandan highlighted commodities as a key sector due to supply constraints and demand trends, while remaining cautious on IT. He also sees opportunities in defence, healthcare, and metals over the medium term.
IKS announces acquisition of Nasdaq-listed TruBridge Inc.
Inventurus Knowledge Solutions, Inc. (IKS), the U.S. subsidiary of Inventurus Knowledge Solutions (IKS Health), announced it has entered into a definitive agreement to acquire TruBridge, Inc. (NASDAQ: TBRG) (TruBridge), a prominent provider of healthcare technology solutions for rural and community hospitals. This proposed strategic acquisition underscores a commitment to broaden access to high-quality care and support the clinicians and hospitals that serve communities across the United States.

Premji Invest backs Maharashtra-based hospital chain NewEra Hospitals
Premji Invest has funded NewEra Hospitals to expand its Maharashtra footprint from 350 to 800 beds. The capital will help launch three new facilities in Nagpur to bridge regional quaternary healthcare gaps.
Sensex dives 850 pts, Nifty slips below 24,200 amid oil shock and weak global cues
The equity benchmark indices Sensex and Nifty tumbled on Thursday, extending losses for a second straight session. Firm crude oil prices and ongoing geopolitical tensions rattled sentiment. Brent crude surged for the fourth consecutive day to around $103 per barrel amid uncertainty over US-Iran talks and fresh concerns around the Strait of Hormuz. Weak Asian cues and persistent foreign fund outflows deepened the sell-off. The Nifty slipped below the 24,200 mark, dragged by auto, PSU banks and consumer durables stocks, while pharma and healthcare shares saw selective buying. Investors stayed cautious, closely tracking the ongoing Q4 earnings season for further triggers.
BMO raises Healthcare Services Group stock price target on solid Q1 results - Investing.com India
BMO raises Healthcare Services Group stock price target on solid Q1 resultsInvesting.com India

Kotak's Nilesh Shah sees opportunities in banks, cement, healthcare
Nilesh Shah sees selective opportunities in banking, cement and healthcare, favouring resilient businesses amid ongoing market uncertainty.

Max Healthcare Institute GST demand of ₹55 crore fully withdrawn after rectification order
Shares of Max Healthcare Institute Ltd ended at ₹1,021.50, up by ₹11.15, or 1.10%, on the BSE.

AVI Polymers board to meet on Apr 27 to discuss results, dividend, mull healthcare entry
AVI Polymers board will meet April 27 2026 to approve FY26 audited results, consider up to 50 percent dividend, and review an AI led healthcare tech expansion via AVI AI Technologies
'Weak and lacklustre': Why Jefferies is disappointed with Wipro earnings as ADRs fall nearly 3%
Wipro’s March quarter results missed expectations, with weak revenue growth, declining profit, and soft guidance. Jefferies highlighted slowing deal momentum, weakness in BFSI and healthcare, and client-specific declines, raising concerns over near-term growth despite stable margins and a buyback announcement.
Eye on aspirational India, medical tourism, Max Healthcare steps up bed capacity expansion
Max Healthcare Institute Ltd is expanding capacity to 10,000 beds over the next 3–4 years, investing ₹4,000–5,000 crore to meet rising domestic demand and boost medical tourism.
NCLEX-RN explained: What has changed and why it matters for Indian nurses
The NCLEX-RN exam, a crucial step for Indian nurses seeking overseas careers, has adopted a new format emphasizing clinical judgment and real-world application. This shift, particularly impacting Kerala's nursing talent, requires a move from rote memorization to conceptual understanding and practical problem-solving, aligning preparation with global healthcare demands.
Wipro Q4 Preview: Profit may fall on margin pressures. Is buyback the only thing to cheer?
Wipro is expected to report steady revenue growth but weaker profitability in the March quarter, impacted by wage hikes, acquisition-related costs and subdued discretionary spending. Sequential growth remains muted despite acquisition support, while BFSI shows resilience, and healthcare remains weak. Investors will closely track margins, deal pipeline and AI outlook.